Prospects for using risk scores in polygenic medicine
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Genome-wide association studies have made strides in identifying common variation associated with disease. The modest effect sizes preclude risk prediction based on single genetic variants, but polygenic risk scores that combine thousands of variants show some predictive ability across a range of complex traits and diseases, including neuropsychiatric disorders. Here, we consider the potential for translation to clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Biological insights from 108 schizophrenia-associated genetic loci
Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) · Nature · doi:10.1038/nature13595 · Cited by 7,577
iPSYCH-Broad Autism Group, Weiner, D. J., Psychiatric Genomics Consortium Autism Group, Wigdor, E. M., Ripke, S., Walters, R. K., Kosmicki, J. A., Grove, J., Samocha, K. E., Goldstein, J. I., et al. (2017) · Nature Genetics · doi:10.1038/ng.3863 · Cited by 516
Genome-wide association analysis identifies 30 new susceptibility loci for schizophrenia
Li, Z., Chen, J., Yu, H., He, L., Xu, Y., Zhang, D., Yi, Q., Li, C., Li, X., Shen, J., et al. (2017) · Nature Genetics · doi:10.1038/ng.3973 · Cited by 442 · cited 1×
“These properties, combined with the smaller number of research studies available, mean that the predictive ability of the PRS in non-European populations is currently limited [8, 10].”
BackgroundCommon alleles contribute to schizophrenia in CNV carriers
Tansey, K. E., Rees, E., Linden, D. E., Ripke, S., Chambert, K. D., Moran, J. L., McCarroll, S. A., Holmans, P., Kirov, G., Walters, J., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.143 · Cited by 132 · cited 1×
“For example, schizophrenia PRSs have a moderating influence in carriers of high-risk copy number variants (CNVs), with schizophrenia cases carrying a high-risk CNV having a higher PRS than control individuals, implying that rare and common risk variants together confer liability to schizophrenia [6].”
Background
Cited by
Võsa, U., Claringbould, A., Westra, H.-J., Bonder, M. J., Deelen, P., Zeng, B., Kirsten, H., Saha, A., Kreuzhuber, R., Yazar, S., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00913-z · Cited by 2,607
Unraveling the polygenic architecture of complex traits using blood eQTL metaanalysis
Võsa, U., Claringbould, A., Westra, H.-J., Bonder, M. J., Deelen, P., Zeng, B., Kirsten, H., Saha, A., Kreuzhuber, R., Kasela, S., et al. (2018) · doi:10.1101/447367 · Cited by 2,607
Defining the genetic, genomic, cellular, and diagnostic architectures of psychiatric disorders
Sullivan, P. F., & Geschwind, D. H. (2019) · Cell · doi:10.1016/j.cell.2019.01.015 · Cited by 452
“Multiple clinical questions could be addressed: for an individual with multiple comorbidities (ADHD, ASD, OCD), do the three GRSs indicate that one is the logical focus of treatment? Should this person with MDD and a high BIP GRS receive a mood stabilizer, as well as an antidepressant? Can we identify people with post…”
BackgroundThe multiplex model of the genetics of Alzheimer's disease
Sims, R., Hill, M., & Williams, J. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0599-5 · Cited by 466
Richardson, T. G., Harrison, S., Hemani, G., & Davey Smith, G. (2019) · eLife · doi:10.7554/elife.43657 · Cited by 198
“As such, they hold considerable potential to improve early disease prognosis and treatment plan formulation (Lewis and Vassos, 2017).”
Background
Metadata
- Authors
- Lewis, C. M., & Vassos, E.
- Venue
- Genome Medicine
- Published
- 2017-11-13
- Volume
- 9
- Issue
- 1
- Pages
- 96-96
- ISSN
- 1756-994X (ISSN-L)
- OpenAlex
- W2769997711
- Cited by
- 177
- References
- 4
- FWCI
- 14.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Prospects for using risk scores in polygenic medicine. https://app.cochat.ai/papers/10.1186/s13073-017-0489-y
- The paper
- Lewis, C. M., & Vassos, E. (2017). Prospects for using risk scores in polygenic medicine. Genome Medicine. https://doi.org/10.1186/s13073-017-0489-y
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.